CIPLA:NSE
Cipla Ltd
၁,၃၄၂.၄၀ ₹
arrow_upward
+၀.၅၂%(+၆.၉၀) 1D
အောက် ၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀ · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CIPLA...
Open
၁,၃၃၅.၀၀ ₹
High
၁,၃၄၄.၉၀ ₹
Low
၁,၃၂၃.၂၀ ₹
Mkt. cap
ဋေ ၁.၀၉ သိန်း
Avg. vol.
၉.၃၇ သိန်း
Volume
၅.၇၆ သိန်း
Dividend
၀.၉၇%
Quarterly dividend
၃.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇွန် ၅
P/E ratio
၃၂.၁၉
52-wk high
၁,၆၇၃.၀၀ ₹
52-wk low
၁,၁၆၅.၇၀ ₹
EPS
၄၁.၇၀ ₹
Shares outstanding
၈၀.၅၇ ကုဋေ
No. of employees
၃ သောင်း
Open
၁,၃၃၅.၀၀ ₹
High
၁,၃၄၄.၉၀ ₹
Low
၁,၃၂၃.၂၀ ₹
Mkt. cap
ဋေ ၁.၀၉ သိန်း
Avg. vol.
၉.၃၇ သိန်း
Volume
၅.၇၆ သိန်း
Dividend
၀.၉၇%
Quarterly dividend
၃.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇွန် ၅
P/E ratio
၃၂.၁၉
52-wk high
၁,၆၇၃.၀၀ ₹
52-wk low
၁,၁၆၅.၇၀ ₹
EPS
၄၁.၇၀ ₹
Shares outstanding
၈၀.၅၇ ကုဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၂၁ မိနစ်
GeneDx Holdings (WGS) Launches Easy Order As Pediatric Testing Narrative Shapes Valuation
Moomoo
·
ပြီးခဲ့သည့် ၄၂ မိနစ်
S&P 500 and Nasdaq Hit Record Highs; Memory Chip Stocks Plunge as SK Hynix (SKHY.US) Drops Over 6%
TheStreet Pro
·
ပြီးခဲ့သည့် ၁ နာရီ
Continued Broadening Lifts S&P 500 to First Record Since August
CNBC
·
ပြီးခဲ့သည့် ၃ နာရီ
Chart: A look at the S&P 500's remarkable and defiant trip to a new record
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees၃.၁၄ သောင်း
Founded၁၉၃၅
Headquartersမွမ်ဘိုင်းမြို့, မဟာရာရှ်ထရာ, အိန္ဒိယ
Sector-
Websitecipla.com